Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Merck & Company (MRK)

80.25   -0.9 (-1.11%) 01-27 06:08
Open: 81.15 Pre. Close: 81.15
High: 81.15 Low: 80.13
Volume: 7,139,482 Market Cap: 203,035M
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; Intec Pharma Ltd.; and Transcenta Holding Ltd. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 81.38 - 81.831 81.831 - 82.197
Low: 78.717 - 79.364 79.364 - 79.89
Close: 79.303 - 80.258 80.258 - 81.034

Technical analysis

as of: 2021-01-26 4:46:38 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 96.47     One year: 99.98
Support: Support1: 77.74    Support2: 64.68
Resistance: Resistance1: 82.60    Resistance2: 85.60
Pivot: 82.38
Moving Average: MA(5): 81.20     MA(20): 82.05
MA(100): 81.28     MA(250): 80.31
MACD: MACD(12,26): 0.04     Signal(9): 0.35
Stochastic oscillator: %K(14,3): 15.80     %D(3): 22.07
RSI: RSI(14): 42.75
52-week: High: 89.20  Low: 65.25  Change(%): -8.0
Average Vol(K): 3-Month: 897016  10-Days: 928126

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MRK has closed above bottom band by 7.2%. Bollinger Bands are 2.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 26 Jan 2021
Merck scraps Covid-19 vaccine programs after they fail to measure up on efficacy in another major setback in the global fight - Endpoints News

Tue, 26 Jan 2021
Merck Announces Second-Quarter 2021 Dividend - Business Wire

Tue, 26 Jan 2021
Merck Halts Development Of Coronavirus Vaccines - The Onion

Mon, 25 Jan 2021
Judge orders Merck documents on anti-baldness drug Propecia unsealed - Reuters

Mon, 25 Jan 2021
Berkshire Holding Merck Dips on Covid-19 Vaccine Program Termination - Yahoo Finance

Mon, 25 Jan 2021
Vaccine Roundup: Merck Wipes Out (and More) | In the Pipeline - Science Magazine

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 2,530
Shares Float (M) 2,510
% Held by Insiders 0.08
% Held by Institutions 75.98
Shares Short (K) 13,590
Shares Short P. Month (K) 13,460

Stock Financials

EPS 4.530
EPS Est This Year 3.870
EPS Est Next Year 4.160
Book Value (p.s.) 11.540
Profit Margin 24.33
Operating Margin 32.95
Return on Assets (ttm) 11.3
Return on Equity (ttm) 41.1
Qtrly Rev. Growth 1.2
Gross Profit (p.s.) 13.312
Sales Per Share 18.715
EBITDA (p.s.) 7.514
Qtrly Earnings Growth 54.70
Operating Cash Flow (M) 11,040
Levered Free Cash Flow (M) 8,650

Stock Valuations

PE Ratio 17.72
PEG Ratio 1.26
Price to Book value 6.95
Price to Sales 4.29
Price to Cash Flow 18.39

Stock Dividends

Dividend 2.380
Forward Dividend 2.600
Dividend Yield 0.03
Dividend Pay Date 2021-01-07
Ex-Dividend Date 2020-12-13
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.